Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: Impact of mandatory central pathology review at a large referral hospital

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 8, 2013, Pages 1650-1655

  Shah, Rajal B ^a   Montgomery, Jeffrey S ^b   Montie, James E ^b   Kunju, Lakshmi P ^b  

^a MIRACA LIFE SCIENCES   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Urothelial carcinoma; Variant or divergent histologic differentiation

Indexed keywords

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; COMMUNITY HOSPITAL; CYSTECTOMY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPHOEPITHELIOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

UROTHELIAL CARCINOMA; VARIANT OR DIVERGENT HISTOLOGIC DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, TRANSITIONAL CELL; COMMUNITY HEALTH CENTERS; CYSTECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATHOLOGY, CLINICAL; PROGNOSIS; REFERRAL AND CONSULTATION; SECONDARY CARE CENTERS; TERTIARY CARE CENTERS; URINARY BLADDER NEOPLASMS;

EID: 84886295996     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2012.04.009     Document Type: Article

References (17)

1. World Health Organization Classification of Tumors 2004, IARC press, Lyon, France. S.G. Eble JN, J.I. Epstein, I.A. Sesterhenn (Eds.).
2. Wasco M.J., Daignault S., Zhang Y., et al. Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection. Urology 2007, 70:69-74.
3. Perez-Montiel D., Wakely P.E., Hes O., et al. High-grade urothelial carcinoma of the renal pelvis: Clinicopathologic study of 108 cases with emphasis on unusual morphologic variants. Mod Pathol 2006, 19:494-503.
4. Billis A., Schenka A.A., Ramos C.C., et al. Squamous and/or glandular differentiation in urothelial carcinoma: Prevalence and significance in transurethral resections of the bladder. Int Urol Nephrol 2001, 33:631-633.
5. Domanowska E., Jozwicki W., Domaniewski J., et al. Muscle-invasive urothelial cell carcinoma of the human bladder: Multidirectional differentiation and ability to metastasize. Hum Pathol 2007, 38:741-746.
6. Jozwicki W., Domaniewski J., Skok Z., et al. Usefulness of histologic homogeneity estimation of muscle-invasive urinary bladder cancer in an individual prognosis: A mapping study. Urology 2005, 66:1122-1126.
7. Black P.C., Brown G.A., Dinney C.P. The impact of variant histology on the outcome of bladder cancer treated with curative intent. Urol Oncol 2009, 27:3-7.
8. Weizer A.Z., Wasco M.J., Wang R., et al. Multiple adverse histological features increase the odds of under staging T1 bladder cancer. J Urol 2009, 182:59-65. Discussion.
9. Kamat A.M., Dinney C.P., Gee J.R., et al. Micropapillary bladder cancer: A review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients. Cancer 2007, 110:62-67.
10. Wasco MJ, Daignault S, Bradley D, Shah RB. Nested variant of urothelial carcinoma: A clinicopathologic and immunohistochemical study of 30 pure and mixed cases. Hum Pathol;41:163-71.
11. Williamson S.R., Zhang S., Lopez-Beltran A., et al. Lymphoepithelioma-like carcinoma of the urinary bladder: Clinicopathologic, immunohistochemical, and molecular features. Am J Surg Pathol 2011, 35:474-483.
12. Kassouf W., Agarwal P.K., Grossman H.B., et al. Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy. Urology 2009, 73:147-152.
13. Ghoneim I.A., Miocinovic R., Stephenson A.J., et al. Neoadjuvant systemic therapy or early cystectomy?. Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder. Urology 2011, 77:867-870.
14. Brimo F., Schultz L., Epstein J.I. The value of mandatory second opinion pathology review of prostate needle biopsy interpretation before radical prostatectomy. J Urol 2010, 184:126-130.
15. Kronz J.D., Westra W.H., Epstein J.I. Mandatory second opinion surgical pathology at a large referral hospital. Cancer 1999, 86:2426-2435.
16. Sharkey F.E., Sarosdy M.F. The significance of central pathology review in clinical studies of transitional cell carcinoma in situ. J Urol 1997, 157:6-70. Discussion 70-1.
17. Sangoi A.R., Beck A.H., Amin M.B., et al. Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists. Am J Surg Pathol 2010, 34:1367-1376.